CHARLOTTE STARK: Open Payments
NPI 1174521702 · VAN BUREN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 14 payments from 9 companies in 2025. Trend: 2023 $53 · 2024 $174 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Amgen Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: XIFAXAN, AIRSUPRA, OTEZLA, CAPLYTA, Cologuard Collection Kit, Wegovy, BREZTRI, REXULTI.
Industry payments across AR — which companies pay providers there.
